A07 D
Alternative Names: A07-DLatest Information Update: 07 May 2024
At a glance
- Originator Endevica Bio
- Class Obesity therapies; Peptides
- Mechanism of Action Melanocortin type 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Obesity